Mark G. Currie
2017
In 2017, Mark G. Currie earned a total compensation of $2.6M as Former Senior Vice President, Chief Scientific Officer and President of R&D at Ironwood Pharmaceuticals, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,000 |
|---|---|
| Option Awards | $1,936,650 |
| Salary | $470,000 |
| Other | $8,040 |
| Total | $2,624,690 |
Currie received $1.9M in option awards, accounting for 74% of the total pay in 2017.
Currie also received $210K in non-equity incentive plan, $470K in salary and $8K in other compensation.
Rankings
In 2017, Mark G. Currie's compensation ranked 4,229th out of 14,666 executives tracked by ExecPay. In other words, Currie earned more than 71.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,229 out of 14,666 | 71st |
Division Manufacturing | 1,483 out of 5,772 | 74th |
Major group Chemicals And Allied Products | 424 out of 2,075 | 80th |
Industry group Drugs | 325 out of 1,731 | 81st |
Industry Pharmaceutical Preparations | 258 out of 1,333 | 81st |
Source: SEC filing on April 26, 2019.
Currie's colleagues
We found four more compensation records of executives who worked with Mark G. Currie at Ironwood Pharmaceuticals in 2017.